| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Revenue | 1,173 | 564 | ||
| Cost of sales | 400 | 319 | ||
| Gross profit | 773 | 245 | ||
| Research and development | 428 | 503 | ||
| Sales and marketing | 1,538 | 1,119 | ||
| General and administrative | 2,199 | 1,480 | ||
| Total operating expenses | 4,165 | 3,102 | ||
| Loss from operations | -3,392 | -2,857 | ||
| Other income (expense), net | - | 0 | ||
| Interest expense | - | 0 | ||
| Gain on investments | 53 | 88 | ||
| Total other income, net | 53 | 88 | ||
| Net loss | -3,339 | -2,769 | ||
| Foreign currency translation adjustment | - | 0 | ||
| Total comprehensive loss | -3,339 | -2,769 | ||
| Basic (in dollars per share) | -0.4 | -0.36 | ||
| Basic (in shares) | 8,250 | 7,591 | ||
| Diluted (in dollars per share) | -0.4 | -0.36 | ||
| Diluted (in shares) | 8,250 | 7,591 | ||
Tenon Medical, Inc. (TNONW)
Tenon Medical, Inc. (TNONW)